SG Americas Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,000
Closed -$143K 3348
2024
Q3
$143K Hold
13,000
﹤0.01% 2774
2024
Q2
$156K Hold
13,000
﹤0.01% 2294
2024
Q1
$614K Buy
+13,000
New +$7.1M ﹤0.01% 1335

Other funds holding IDXX

SG Americas Securities's IDXX Position: Q1 2026 in Review

SG Americas Securities reduced its Idexx Laboratories (IDXX) stake by 76% in Q1 2026, selling an estimated $21M and leaving 10,631 shares worth $5.97M. The position accounts for 0.01% of the portfolio, ranked #984.

SG Americas Securities first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $58.2M in Q1 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • SG Americas Securities held 10,631 shares of Idexx Laboratories worth $5.97M as of Q1 2026.
  • SG Americas Securities sold 32,794 Idexx Laboratories shares in Q1 2026, an estimated $21M.
  • Idexx Laboratories made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #984 holding.
  • SG Americas Securities first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • SG Americas Securities's Idexx Laboratories position peaked at $58.2M in Q1 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.